Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07354269 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 21, 2026 (before its estimated April 11, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The goal of this clinical study is to compare the immunogenicity and safety of one dose of sIPV in adolescents or adults aged 7-50 years with that of three doses of DTaP-IPV-Hib Pentavalent Vaccine in Infants Aged 3 Months
Trial Details
NCT Number NCT07354269
Lead Sponsor Sinovac Biotech Co., Ltd
Conditions
(from sponsor)		 Poliomyelitis
Related terms Poliomyelitis
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov